Check-Cap Ltd.
Check-Cap Ltd. (CHEK) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
chek · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Check-Cap Ltd. (CHEK) measures how much investors pay for each dollar of the company's trailing earnings. CHEK's current PE ratio of 2.23x is calculated by dividing its stock price of $1.86 by its TTM earnings per share of $0.66.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2012 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Check-Cap Ltd.You CHEK | $11M | 2.23x | — | $0.66 |
 Acurx Pharmaceuticals, Inc. ACXP | $3M | N/A | — | -$5.31 |
 Adial Pharmaceuticals, Inc. ADIL | $2M | N/A | — | -$11.93 |
 Biofrontera Inc. BFRI | $12M | N/A | — | -$1.04 |
 GBS Inc. GBS | $0M | N/A | — | -$2.00 |
 HCW Biologics Inc. HCWB | $3M | N/A | — | -$3.79 |
 Innovative Eyewear, Inc. LUCY | $4M | N/A | — | -$1.90 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | — | $-4.30 | — | |
2023-12-31 FY2023 | — | $-3.00 | — | |
2022-12-31 FY2022 | — | $-3.37 | — | |
2021-12-31 FY2021 | — | $-4.15 | — | |
2020-12-31 FY2020 | — | $-9.12 | — | |
2019-12-31 FY2019 | — | $-34.65 | — | |
2018-12-31 FY2018 | — | $-52.19 | — | |
2017-12-31 FY2017 | — | $-134.31 | — | |
2016-12-31 FY2016 | — | $-146.10 | — | |
2015-12-31 FY2015 | — | $-247.49 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Check-Cap Ltd. (CHEK) measures how much investors pay for each dollar of the company's trailing earnings. CHEK's current PE ratio of 2.23x is calculated by dividing its stock price of $1.86 by its TTM earnings per share of $0.66.
Frequently asked questions
CHEK pe ratio · 6 questionsCHEK's current PE ratio is 2.23x as of 2026-06-08, based on a stock price of $1.86 and TTM EPS of $0.66. Data sourced from Financial Modeling Prep via CHEK's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Check-Cap Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08